Chris Boshoff
President bei SEAGEN INC.
Vermögen: 4 Mio $ am 31.03.2024
Profil
Chris Boshoff is currently the Chief Oncology Officer & Executive Vice President at Pfizer Inc. He is also the President at Seagen Inc. Additionally, he holds the position of Vice President-Translational Oncology at Pfizer (La Jolla).
Previously, he served as a Non-Executive Director at Advanced Oncotherapy Plc in 2013.
Dr. Boshoff obtained a doctorate degree from the University of Pretoria.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PFIZER INC.
0,00% | 28.02.2024 | 156 631 ( 0,00% ) | 4 Mio $ | 31.03.2024 |
Aktive Positionen von Chris Boshoff
| Unternehmen | Position | Beginn |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 27.07.2023 |
| SEAGEN INC. | President | 14.12.2023 |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer (La Jolla) is a private company that provides research services. The company is based in San Diego, CA. The company was founded by Michael R. Jirousek. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Chris Boshoff
| Unternehmen | Position | Ende |
|---|---|---|
| ADVANCED ONCOTHERAPY PLC | Director/Board Member | 25.10.2013 |
Ausbildung von Chris Boshoff
| University of Pretoria | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ADVANCED ONCOTHERAPY PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Pfizer (La Jolla)
Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer (La Jolla) is a private company that provides research services. The company is based in San Diego, CA. The company was founded by Michael R. Jirousek. | Commercial Services |
